Treatment Guideline for Dyslipidemia in Diabetes Mellitus / 임상당뇨병
Journal of Korean Diabetes
;
: 61-64, 2014.
Article
Dans Coréen
| WPRIM
| ID: wpr-726904
ABSTRACT
The recently published 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults published by the American Heart Association (AHA) and American College of Cardiology (ACC) changes the treatment paradigm for high cholesterol. Based on a systematic review of randomized controlled clinical trials (RCTs), the new guideline no longer targets LDL cholesterol (LDL-C) level but focuses on treating cholesterol to reduce atherosclerotic cardiovascular disease (ASCVD) risk. Only data from RCTs of cholesterol-lowering drug therapies with cardiovascular outcomes or meta-analyses of these RCTs were considered. In Type 2 diabetes in those 40~75 years of age with risk factors, the potential benefits of LDL-C reduction with a high-intensity statin are substantial. Because those with diabetes often have a lower LDL-C level than those without diabetes, "goal"-directed therapy often encourages use of a lower statin dose than is supported by the RCTs, and non-statin drugs may be included to address low HDL-C or high triglycerides, for which there is little RCT evidence of an ASCVD event reduction.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Triglycéride
/
Cardiologie
/
Maladies cardiovasculaires
/
Cholestérol
/
Facteurs de risque
/
Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase
/
Diabète
/
Diabète de type 2
/
Traitement médicamenteux
/
Dyslipidémies
Type d'étude:
Essai clinique contrôlé
/
Etude d'étiologie
/
Guide de pratique
/
Facteurs de risque
Limites du sujet:
Adulte
/
Humains
langue:
Coréen
Texte intégral:
Journal of Korean Diabetes
Année:
2014
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS